Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q2 FY26
Investor Presentation
Q2 FY25
Bearish
5
Neutral
5
Bullish
4
Bearish
14
Neutral
5
Bullish
27
Bearish
9
Neutral
0
Bullish
23
Discovery themes featuring this stock
Fischer Medical Ventures Limited specializes in developing advanced, affordable MRI systems, located in the Andhra Pradesh MedTech Zone. It has a significant international footprint and is focused on enhancing medical imaging accessibility worldwide.
The company saw a remarkable growth in revenue, increasing by 118% year-on-year to INR 86 crores for Q2 FY26, and maintains a strong EBITDA margin of 21%.
The core focus is on Radiology and Preventive Healthcare, leveraging Make-In-India and PLI schemes for medical devices to strengthen its market position.
Fischer Medical has successfully integrated AI in diagnostic imaging, enhancing its capabilities in telemedicine and preventative health through innovations in MRI technology.
It is expanding its presence in international markets such as MENA, Southeast Asia, and Africa, reflecting growing export opportunities and a shift in revenue focus beyond India.
Healthcare Equipment & Supplies
Medical Equipment & Supplies
2,494 Cr
Low Risk
63.2
38.6
0.0
6.7
124.20
32.09
Sales CAGR
Profit CAGR
ROE
ROCE
Fischer Medical Ventures Ltd (FISCHER) is currently trading at 37.86 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Fischer Medical Ventures Limited specializes in developing advanced, affordable MRI systems, located in the Andhra Pradesh MedTech Zone. It has a significant international footprint and is focused on enhancing medical imaging accessibility worldwide. The company saw a remarkable growth in revenue, increasing by 118% year-on-year to INR 86 crores for Q2 FY26, and maintains a strong EBITDA margin of 21%. The core focus is on Radiology and Preventive Healthcare, leveraging Make-In-India and PLI schemes for medical devices to strengthen its market position. Fischer Medical has successfully integrated AI in diagnostic imaging, enhancing its capabilities in telemedicine and preventative health through innovations in MRI technology. It is expanding its presence in international markets such as MENA, Southeast Asia, and Africa, reflecting growing export opportunities and a shift in revenue focus beyond India.
Over the past 52 weeks, Fischer Medical Ventures Ltd has traded between a low of ₹32.09 and a high of ₹124.20. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Fischer Medical Ventures Ltd has a market capitalization of approximately 2,494.36. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Fischer Medical Ventures Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 63.23 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 2,494.36 Cr, Fischer Medical Ventures Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Fischer Medical Ventures Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Fischer Medical Ventures Ltd is 63.23. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The plan to establish five regional Medical Value Tourism Hubs and increase trauma care capacity in district hospitals are the most significant, as they create direct, large-scale demand for the company's MRI and CT systems.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
37.86 | 2,494 Cr | 63.23 | 6.67 | 0.01 | 5.54 | 7.87 | 8.44 | ||
234.20 | 1,277 Cr | 44.06 | 5.25 | 0.00 | 13.74 | 14.03 | 8.99 | ||
207.10 | 1,109 Cr | 77.43 | 1.75 | 0.00 | 2.26 | 4.09 | 1.21 | ||
474.60 | 1,107 Cr | 24.55 | 2.56 | 0.00 | 21.29 | 14.24 | 0.00 | ||
492.85 | 877 Cr | 32.21 | 5.33 | 0.00 | 15.39 | 15.75 | 8.44 | ||
434.55 | 754 Cr | 73.60 | 4.33 | 0.00 | 5.88 | 7.65 | 5.02 | ||
154.65 | 689 Cr | 17.97 | 1.64 | 0.39 | 9.14 | 10.71 | 5.87 | ||
| Median: 7 Co. | — | 234.20 | 1,107 Cr | 44.06 | 4.33 | 0.00 | 9.14 | 10.71 | 5.87 |
Board meeting - Results
Board to meet on 29 May 2026 to consider and record audited standalone and consolidated financial results for quarter and year ended 31 Mar 2026, consider recommending a dividend, and transact other agenda items; trading window closed.
Board Meeting/Results
Fischer Medical Ventures will hold a Board meeting on 29-May-2026 to consider and take on record audited standalone and consolidated financial results for the quarter and year ended 31-Mar-2026 and may recommend a dividend.
